We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Places Hold on Idenix Trials, Citing Elevated Liver Enzymes
FDA Places Hold on Idenix Trials, Citing Elevated Liver Enzymes
September 15, 2010
The FDA has placed Idenix’s clinical trials for its hepatitis C (HCV) treatments on hold after elevated liver enzymes were noted.